Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 4.83M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -11.62M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 74.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 188.00% |
| Dividend | N/A | Price/Book | 0.10 | EPS next 5Y | - | 52W High Chg | - |
| Recommedations | - | Quick Ratio | 16.35 | Shares Outstanding | 34.48M | 52W Low Chg | 1,067.00% |
| Insider Own | - | ROA | -15.06% | Shares Float | - | Beta | 1.45 |
| Inst Own | 1.26% | ROE | -25.67% | Shares Shorted/Prior | 48.45K/110.23K | Price | 0.00350 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 708 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 38 | Change | 0.00% |
About MYREXIS INC
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.